WASHINGTON, March 25 -- Food and Drug Administration has issued a rule called: Nonprescription Drug Product With an Additional Condition for Nonprescription Use.
The rule was published in the Federal Register on March 25 by Robert F. Kennedy, Secretary, Department of Health and Human Services.
Summary: In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review, " the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use, " (ACNU) was delayed until March 21, 2025. Additional time is needed for review; therefore, the delay is extended for an additional 60 days.
For more information, contact Myla Dellupac, Cente...